Core Insights - Shenhe Reform and Innovation Demonstration Zone has achieved a significant milestone with the approval of Shenyang Pengyue Technology Co., Ltd.'s cardiac cryoablation device and disposable sterile cryoablation probe by the National Medical Products Administration, marking a breakthrough in domestic medical devices for cardiac atrial fibrillation treatment [1][2] Group 1: Product Overview - The cardiac cryoablation device is the core of a complete cryoablation system solution, responsible for precise control of refrigerant delivery and recovery, ensuring stability and safety during the ablation process [2] - The disposable sterile cryoablation probe is a key instrument that directly targets the myocardial area, made from special alloy materials, allowing for full-path cardiac ablation treatment with a single probe, significantly reducing treatment costs [2] Group 2: Technological Advancements - The device has achieved domestic technological breakthroughs in refrigerant selection, active rewarming design, probe vacuum insulation, and flexible structure, with its backside temperature feedback technology being an international first [2] - These advancements are expected to disrupt the long-standing dominance of foreign products in the relevant medical field, providing better treatment options for domestic clinicians and patients [2]